Citation: Zhang Yan, Wang Yunyun, Zhao Yuxun, Zhang Chenglong, Gu Wen, Wang Zhonglong, Zhu Yongqiang, Wang Shifa. Camphor-Based Thiosemicarbazone Analogues Induced G2 Cell Cycle Arrest and Apoptosis via Reactive Oxygen Species (ROS)-Mediated Mitochondrial Pathway in Human Breast Cancer Cells[J]. Chinese Journal of Organic Chemistry, ;2020, 40(8): 2374-2386. doi: 10.6023/cjoc202001021 shu

Camphor-Based Thiosemicarbazone Analogues Induced G2 Cell Cycle Arrest and Apoptosis via Reactive Oxygen Species (ROS)-Mediated Mitochondrial Pathway in Human Breast Cancer Cells

a.
Co-Innovation Center of Efficient Processing and Utilization of Forest Resources, College of Chemical Engineering, Nanjing Forestry University, Nanjing 210037
b.
Jiangsu Chia Tai Fenghai Pharmaceutical Co. Ltd, Nanjing 210033

Corresponding author: Zhu Yongqiang, zhyqscu@163.com Wang Shifa, wangshifa65@163.com
Received Date: 14 January 2020
Revised Date: 22 May 2020
Available Online: 8 June 2020
Fund Project: Natural National Science Foundation of China 31470592Doctorate Fellowship Foundation of Nanjing Forestry University 31470592Key Technology of Green Processing and Efficient Utilization on Oleoresin 2016YFD0600804Project supported by the Doctorate Fellowship Foundation of Nanjing Forestry University, the Natural National Science Foundation of China (No. 31470592), the University Science Research Project of Jiangsu Province (No. 14KJ220001) and the Key Technology of Green Processing and Efficient Utilization on Oleoresin (No. 2016YFD0600804)University Science Research Project of Jiangsu Province 14KJ220001

Figures(7)

22 novel camphor-based thiosemicarbazone derivatives were synthesized using camphor-based thiosemicarbazone as material and their structures were determined by ¹H NMR, ¹³C NMR and HRMS. The crystal structure of 2-(3-(pyridin-4-ylmethylene)-1, 7, 7-trimethylbicyclo[2.2.1]heptan-2-ylidene)hydrazinecarbothioamide (3n) was determined by single crystal X-ray diffraction. The derivatives were screened in vitro for anticancer activities against human breast cancer cell line (MDA-MB-231), human lung adenocarcinoma cell line (A549), human multiple myeloma cell line (RPMI-8226) and toxicity against a normal human cell line (GES-1) by 3-(4, 5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS). It was found that majority of the tested analogs showed moderate to significant antitumor activity against selected cancer cell lines. Noticeably, 2-(3-(anthracen-9-ylmethylene)-1, 7, 7-trimethylbicyclo[2.2.1]heptan-2-ylidene)-hydrazinecarbothioamide (3s) exhibited selective anti-tumor activities against MDA-MB-231 cells (IC₅₀=3.90±0.04 μmol·L^-1) and low toxicity to GES-1 cells (IC₅₀>50 μmol·L^-1). In the process of exploring the underlying mechanism of 3s, it was found that compound 3s could cause G2 phase arrest and apoptosis in MDA-MB-231 cells by overproduction of intracellular reactive oxygen species and collapse of mitochondrial membrane potential. The measured results were confirmed by western blot assay.
- camphor-based thiosemicarbazone,
- anti-tumor activity,
- G2 phase arrest,
- reactive oxygen species (ROS),
- mitochondrial apoptosis pathway
1. [1]
  Xu Z., Zhao S. J., Liu Y.Eur. J. Med. Chem., 2019, 183:111700.
2. [2]
  Zhang L., Xu Z.Eur. J. Med. Chem., 2019, 181:111587.
3. [3]
  Magalhaes Moreira D. R., de Oliveira A. D., Teixeira de Moraes Gomes P. A., de Simone C. A., Villela F. S., Ferreira R. S., Leite A. C.Eur. J. Med. Chem., 2014, 75:467.
4. [4]
  De Melos J. L., Torres-Santos E. C., Faioes Vdos S., Del Cistia Cde N., Sant'Anna C. M., Rodrigues-Santos C. E., Echevarria A.Eur. J. Med. Chem., 2015, 103:409.
5. [5]
  Linciano P., Moraes C. B., Alcantara L. M., Franco C. H., Pascoalino B., Freitas-Junior L. H., Costi M. P.Eur. J. Med. Chem., 2018, 146:423.
6. [6]
  El-Sharief M. A., Abbas S. Y., El-Bayouki K. A., El-Gammal E. W.Eur. J. Med. Chem., 2013, 67:263.
7. [7]
  Zhang X., Guo H., Li Z., Song F., Wang W., Dai H., Wang J.Eur. J. Med. Chem., 2015, 101:419.
8. [8]
  Banerjee D., Yogeeswari P., Bhat P., Thomas A., Srividya M., Sriram D.Eur. J. Med. Chem., 2011, 46:106.
9. [9]
  Kesel A. J.Eur. J. Med. Chem., 2011, 46:1656.
10. [10]
  Chavarria G. E., Horsman M. R., Arispe W. M., Kumar G. D., Chen S. E., Strecker T. E., Trawick M. L.Eur. J. Med. Chem., 2012, 58:568.
11. [11]
  Pervez H., Khan N., Zaib S., Yaqub M., Naseer M. M., Tahir M. N., Iqbal J.Bioorg. Med. Chem., 2017, 25:1022.
12. [12]
  Song S., You A., Chen Z., Zhu G., Wen H., Song H., Yi W.Eur. J. Med. Chem., 2017, 139:815.
13. [13]
  De Oliveira J. F., Lima T. S., Vendramini-Costa D. B., de Lacerda Pedrosa S. C. B., Lafayette E. A., da Silva R. M. F., de Lima M.Eur. J. Med. Chem., 2017, 136:305.
14. [14]
  Vandresen F., Falzirolli H., Almeida Batista S. A., da Silva-Giardini A. P., de Oliveira D. N., Catharino R. R., da Silva C. C.Eur. J. Med. Chem., 2014, 79:110.
15. [15]
  Lukmantara A. Y., Kalinowski D. S., Kumar N., Richardson D. R.Bioorg. Med. Chem. Lett., 2013, 23:967.
16. [16]
  Rao V. A., Klein S. R., Agama K. K., Toyoda E., Adachi N., Pommier Y., Shacter E. B.Cancer Res., 2009, 69:948.
17. [17]
  Malarz K., Mrozek-Wilczkiewicz A., Serda M., Rejmund M., Musiol R.Oncotarget, 2018, 9:17689.
18. [18]
  Lovejoy D. B., Richardson D. R.Blood, 2002, 100:666.
19. [19]
  Da Silva A. P., Martini M. V., de Oliveira C. M., Cunha S., de Carvalho J. E., Ruiz A. L., da Silva C. C.Eur. J. Med. Chem., 2010, 45:2987.
20. [20]
  Bao M., Yang Y., Gu W., Xu X., Cao M., Wang S.Chin. J. Org. Chem., 2014, 34:2146(in Chinese).
21. [21]
  Sun N., Wang X., Ding Z., Zhang Q., Xu X., Xu H., Wang S.Chin. J. Org. Chem., 2016, 36:2489(in Chinese).
22. [22]
  Rui J., Cai T., Yang J., Yang Y., Xu X., Wang S.J. Nanjing. For. Univ., 2017, 41:149(in Chinese).
23. [23]
  Ma C., Wang Y., Dong F., Wang Z., Zhao Y., Shan Y., Wang S.Chem. Biol. Drug Des., 2019, 94:1457.
24. [24]
  Wang Y., Wang Z., Kuang H., Zhang Y., Gu W., Zhu Y., Wang S.Chem. Biol. Drug Des., 2019, 94:1281.
25. [25]
  Sokolova A. S., Yarovaya O. C., Korchagina D. V., Zarubaev V. V., Tretiak T. S., Anfimov P. M., Salakhutdinov N. F.Bioorg. Med. Chem., 2017, 127:661.
26. [26]
  Stavrakov G., Valcheva V., Philipova I., Doytchinova I.Eur. J. Med. Chem., 2013, 70:372.
27. [27]
  Sokolova A. S., Yarovaya O. C., Korchagina D. V., Zarubaev V. V., Tretiak T. S., Anfimov P. M., Salakhutdinov N. F.Bioorg. Med. Chem., 2014, 22:2141.
28. [28]
  Kuranov S. O., Tsypysheva I. P., Khvostov M. V., Zainullina L. F., Borisevich S. S., Vakhitova Y. V., Salakhutdinov N. F.Bioorg. Med. Chem., 2018, 26:4402.
29. [29]
  Hossain M., Das U., Dimmock J. R.Eur. J. Med. Chem., 2019, 183:111687.
30. [30]
  Dan W., Dai J.Eur. J. Med. Chem., 2020, 187:111980.
31. [31]
  Zhu M., Wang J., Xie J., Chen L., Wei X., Jiang X., Bao M., Qiu Y., Chen Q., Li W., Jiang C., Zhou X., Jiang L., Qiu P., Wu J.Eur. J. Med. Chem., 2018, 157:1395.
32. [32]
  Liu C., Wen R., He M., Yi X., Ye X., Fang L.Chin. J. Appl. Chem., 2017, 38:900(in Chinese).
33. [33]
  Zhang H., Qian Y., Zhu D., Yang X., Zhu H.Eur. J. Med. Chem., 2011, 46:4702.
34. [34]
  Simon H. U., Haj-Yehia A., Levi-Schaffer F.Apoptosis, 2000, 5:415.
35. [35]
  Circu M. L., Aw T. Y.Free Radical Biol. Med., 2010, 48:749.
36. [36]
  Dharmaraja A. T.J. Med. Chem., 2017, 60:3221.
37. [37]
  Yamada Y., Harashima H.Adv. Drug Delivery Rev., 2008, 60:1439.
38. [38]
  Galluzzi L., Zamzami N., de La Motte Rouge T., Lemaire C., Brenner C., Kroemer G.Apoptosis, 2007, 12:803.
39. [39]
  Jin Z., El-Deiry W. S.Cancer Biol. Ther., 2005, 4:139.
40. [40]
  Martinou J. C., Desagher S., Antonsson B.Nat. Cell Biol., 2005, 2:41.
41. [41]
  Xiong S., Mu T., Wang G., Jiang X.Protein Cell, 2014, 5:737.
1. [1]
  Zhongyu Wang , Lijun Wang , Huaixin Zhao . DNA-based nanosystems to generate reactive oxygen species for nanomedicine. Chinese Chemical Letters, 2024, 35(11): 109637-. doi: 10.1016/j.cclet.2024.109637
2. [2]
  Qianyun Ye , Yuanyuan Liang , Yuhe Yuan , Xiaohuan Sun , Liqi Zhu , Xuan Wu , Jie Han , Rong Guo . pH-responsive chiral supramolecular cysteine-Zn²⁺-indocyanine green assemblies for triple-level chirality-specific anti-tumor efficacy. Chinese Chemical Letters, 2025, 36(5): 110432-. doi: 10.1016/j.cclet.2024.110432
3. [3]
  Yuanyi Zhou , Ke Ma , Jinfeng Liu , Zirun Zheng , Bo Hu , Yu Meng , Zhizhong Li , Mingshan Zhu . Is reactive oxygen species the only way for cancer inhibition over single atom nanomedicine? Autophagy regulation also works. Chinese Chemical Letters, 2024, 35(6): 109056-. doi: 10.1016/j.cclet.2023.109056
4. [4]
  Chi Zhang , Ning Ding , Yuwei Pan , Lichun Fu , Ying Zhang . The degradation pathways of contaminants by reactive oxygen species generated in the Fenton/Fenton-like systems. Chinese Chemical Letters, 2024, 35(10): 109579-. doi: 10.1016/j.cclet.2024.109579
5. [5]
  Yuanyuan Zeng , Fang Liu , Jun Wang , Bianfei Shao , Tao He , Zhongzheng Xiang , Yan Wang , Shunyao Zhu , Tian Yang , Siting Yu , Changyang Gong , Lei Liu . Fisetin micelles precisely exhibit a radiosensitization effect by inhibiting PDGFRβ/STAT1/STAT3/Bcl-2 signaling pathway in tumor. Chinese Chemical Letters, 2025, 36(2): 109734-. doi: 10.1016/j.cclet.2024.109734
6. [6]
  Weixu Li , Yuexin Wang , Lin Li , Xinyi Huang , Mengdi Liu , Bo Gui , Xianjun Lang , Cheng Wang . Promoting energy transfer pathway in porphyrin-based sp2 carbon-conjugated covalent organic frameworks for selective photocatalytic oxidation of sulfide. Chinese Journal of Structural Chemistry, 2024, 43(7): 100299-100299. doi: 10.1016/j.cjsc.2024.100299
7. [7]
  Mengjie Gao , Zhiqiang Cui , Yue Shen , Yikun Li , Dongxiang Zhang , Xiaoyan Gao , Yaguang Sun , Xin-Dong Jiang , Jianjun Du , Xiaohong Sun . NIR-II emissive aza-BODIPY-based nanoparticles for triggering glioblastoma apoptosis in brain. Chinese Chemical Letters, 2025, 36(5): 110098-. doi: 10.1016/j.cclet.2024.110098
8. [8]
  Xueying Shi , Xiaoxuan Zhou , Bing Xiao , Hongxia Xu , Wei Zhang , Hongjie Hu , Shiqun Shao , Zhuxian Zhou , Youqing Shen , Xiaodan Xu , Jianbin Tang . A β-lapachone-loaded iron-polyphenol nanocomplex enhances chemodynamic therapy through cascade amplification of ROS in tumor. Chinese Chemical Letters, 2025, 36(5): 110178-. doi: 10.1016/j.cclet.2024.110178
9. [9]
  Tiancong Shi , Xi Chen , Xiao Zhou , Hongyi Zhang , Fuping Han , Lihan Cai , Wen Sun , Jianjun Du , Jiangli Fan , Xiaojun Peng . Azaindole-based asymmetric pentamethine cyanine dye for mitochondrial pH detection and near-infrared ratiometric fluorescence imaging of mitophagy. Chinese Chemical Letters, 2025, 36(6): 110408-. doi: 10.1016/j.cclet.2024.110408
10. [10]
  Xiongbo Song , Jinwen Xiao , Juan Wu , Li Sun , Long Chen . Decellularized amniotic membrane promotes the anti-inflammatory response of macrophages via PI3K/AKT/HIF-1α pathway. Chinese Chemical Letters, 2025, 36(1): 109844-. doi: 10.1016/j.cclet.2024.109844
11. [11]
  Ji Zhang , Tong Zhang , Qiao An , Peng Zhang , Cai-Yan Tian , Chun-Mao Yuan , Ping Yi , Zhan-Xing Hu , Xiao-Jiang Hao . Five quinolizidine alkaloids with anti-tobacco mosaic virus activities from two species of Sophora. Chinese Chemical Letters, 2024, 35(6): 108927-. doi: 10.1016/j.cclet.2023.108927
12. [12]
  Xue-Jiao Wang , Jun-Li Xin , Hong Xiang , Ze-Yu Zhao , Yu-Hang He , Haibo Wang , Guangyao Mei , Yi-Cheng Mao , Juan Xiong , Jin-Feng Hu . Holotrichones A and B, potent anti-leukemic lindenane-type sesquiterpene trimers with unprecedented complex carbon skeletons from a rare Chloranthus species. Chinese Chemical Letters, 2024, 35(12): 109682-. doi: 10.1016/j.cclet.2024.109682
13. [13]
  Zhenghua ZHAO , Qin ZHANG , Yufeng LIU , Zifa SHI , Jinzhong GU . Syntheses, crystal structures, catalytic and anti-wear properties of nickel(Ⅱ) and zinc(Ⅱ) coordination polymers based on 5-(2-carboxyphenyl)nicotinic acid. Chinese Journal of Inorganic Chemistry, 2024, 40(3): 621-628. doi: 10.11862/CJIC.20230342
14. [14]
  Zheyi Li , Xiaoyang Liang , Zitong Qiu , Zimeng Liu , Siyu Wang , Yue Zhou , Nan Li . Ion-interferential cell cycle arrest for melanoma treatment based on magnetocaloric bimetallic-ion sustained release hydrogel. Chinese Chemical Letters, 2024, 35(11): 109592-. doi: 10.1016/j.cclet.2024.109592
15. [15]
  Haixian Ren , Yuting Du , Xiaojing Yang , Fangjun Huo , Le Zhang , Caixia Yin . Development of ESIPT-based specific fluorescent probes for bioactive species based on the protection-deprotection of the hydroxyl. Chinese Chemical Letters, 2025, 36(2): 109867-. doi: 10.1016/j.cclet.2024.109867
16. [16]
  Kunya Wang , Bingyu Liu , Daojiang Yan , Jian Bai , Haibo Yu , Youcai Hu . Full biosynthetic pathway of pyrrolobenzoxazines. Chinese Chemical Letters, 2025, 36(1): 109811-. doi: 10.1016/j.cclet.2024.109811
17. [17]
  Yudi Cheng , Xiao Wang , Jiao Chen , Zihan Zhang , Jiadong Ou , Mengyao She , Fulin Chen , Jianli Li . A near-infrared fluorescent probe for visualizing transformation pathway of Cys/Hcy and H₂S and its applications in living system. Chinese Chemical Letters, 2024, 35(5): 109156-. doi: 10.1016/j.cclet.2023.109156
18. [18]
  Xubin Qian , Lei Xu , Xu Ge , Zhun Liu , Cheng Fang , Jianbing Wang , Junfeng Niu . Can perfluorooctanoic acid be effectively degraded using β-PbO₂ reactive electrochemical membrane?. Chinese Chemical Letters, 2024, 35(7): 109218-. doi: 10.1016/j.cclet.2023.109218
19. [19]
  Yunli Xu , Xuwen Da , Lei Wang , Yatong Peng , Wanpeng Zhou , Xiulian Liu , Yao Wu , Wentao Wang , Xuesong Wang , Qianxiong Zhou . Ru(Ⅱ)-based aggregation-induced emission (AIE) agents with efficient ¹O₂ generation, photo-catalytic NADH oxidation and anticancer activity. Chinese Chemical Letters, 2025, 36(5): 110168-. doi: 10.1016/j.cclet.2024.110168
20. [20]
  Wenhao Yan , Shuaiya Xue , Xuerui Zhao , Wei Zhang , Jian Li . Hexagonal boron nitride based slippery liquid infused porous surface with anti-corrosion, anti-contaminant and anti-icing properties for protecting magnesium alloy. Chinese Chemical Letters, 2024, 35(4): 109224-. doi: 10.1016/j.cclet.2023.109224

Get Citation

PDF

XML

Metrics

PDF Downloads(5)
Abstract views(949)
HTML views(88)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142